GI & Endoscopy

Here are five gastroenterologists making headlines during the week of June 5, 2017.

A report in CA: A Cancer Journal for Clinicians reviewed incidence, mortality and survival rates for liver cancer patients.

New South Wales, Australia-based University of Newcastle researcher Jessica Bruce discovered a possible link between stress and immune changes that causes symptoms associated with irritable bowel syndrome to occur, the Newcastle Herald reports.

A study, published in Gastroenterology, examined the effects of prebiotics on body composition and composition of the intestinal microbiota in overweight children.

Here is executive compensation for the CEOs of publicly traded, U.S.-based gastroenterology companies.

A study, presented at the American Society of Clinical Oncology Annual Meeting, examined if researchers could reduce chemotherapy from six months to three months when treating stage III colorectal cancer patients.

John Weippert, DO, is a gastroenterologist at Warren, Ohio-based NEO Gastroenterology and Endoscopy Center.

The FDA awarded Becton, Dickinson and Company's BD Max's extended enteric bacterial panel 510(k) clearance.

Washington, D.C.-based Capital Digestive Care opened a new clinic in Glenn Dale, Md.

Boston Scientific is investing $19 million in a new Galway, Ireland-based RoadRunner endoscopy design facility, Galway Advertiser reports.